Pharmarack
Signals mentioning Pharmarack
- India’s GLP-1 market stabilises as generic semaglutide boom fades
- Delhi HC requires Sun Pharma to seek clearance before semaglutide launch
- India’s GLP-1 weight-loss drug market crosses ₹2,000 crore
- India pharma retail volumes cross 3% in June, first time in 24 months
- Semaglutide channel chokes on Rs 100cr excess stock as April generic rush fades